Rentschler Biopharma’s ATMP facility in Stevenage, UK, receives MHRA approval
UK site now set for clinical production of adeno-associated virus (AAV) vectors for gene therapy
14-Sep-2023 -
Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, including advanced therapy medicinal products (ATMPs), announced that it has received the cGMP Manufacturing Compliance Certificate, following the successful inspection by ...
Advanced Therapy Medicinal Products
cell therapies
gene therapy